COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Sprouting bioprocess as a sustainable tool for enhancing durum wheat (Triticum durum) nutrients and bioactive compounds
- Participatory cooking demonstrations for mothers improve feeding practices of young children in southern Benin
- Quantitative and qualitative assessment of food waste in rural markets in Morocco
- Comparative Analysis of Nutritional Profile of a Formulated Composite Milk Alternative and a Conventional Infant Formula
- Bioactive molecules of grape
- Investigating bacterial gastroenteritis prevalence in the population of Tizi-Ouzou city under the context of social distancing and barrier measures
- Pica in sickle cell disease: nutritional management and implications
- The role of nutrition in strengthening immune system against newly emerging viral diseases: case of SARS-CoV-2
- Nutritional evaluation, oxidative indexes, and functional properties of Irish potatoes, eggs, and red kidney beans based complementary food
- Impact of Lycopene Supplementation on the Physicochemical, and Microbiological Properties of Fresh Goat Cheese: In Production
You may also start an advanced similarity search for this article.
NAJFNR is licensed under